Baxter International Inc. $BAX Shares Purchased by Retirement Systems of Alabama

Retirement Systems of Alabama grew its position in shares of Baxter International Inc. (NYSE:BAX – Free Report) by 25.0% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 135,593 shares of the medical instruments supplier’s stock after purchasing an additional 27,093 shares during the period. Retirement Systems of Alabama’s holdings in Baxter International were worth $3,254,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently modified their holdings of the company. Jones Financial Companies Lllp bought a new position in shares of Baxter International during the 2nd quarter valued at about $26,000. CYBER HORNET ETFs LLC raised its holdings in shares of Baxter International by 52.4% during the 2nd quarter. CYBER HORNET ETFs LLC now owns 2,153 shares of the medical instruments supplier’s stock valued at $46,000 after buying an additional 740 shares in the last quarter. Community Bank N.A. purchased a new position in shares of Baxter International during the 2nd quarter valued at about $46,000. Versant Capital Management Inc raised its holdings in shares of Baxter International by 552.2% during the 2nd quarter. Versant Capital Management Inc now owns 2,413 shares of the medical instruments supplier’s stock valued at $51,000 after buying an additional 2,043 shares in the last quarter. Finally, Wedbush Securities Inc. bought a new stake in Baxter International in the 3rd quarter worth approximately $605,000. 90.19% of the stock is currently owned by hedge funds and other institutional investors.

Baxter International Stock Performance

NYSE BAX opened at $25.53 on Tuesday. The company has a 50-day simple moving average of $24.53 and a two-hundred day simple moving average of $21.70. Baxter International Inc. has a 12-month low of $15.73 and a 12-month high of $30.00. The firm has a market cap of $13.21 billion, a price-to-earnings ratio of -18.10, a PEG ratio of 3.78 and a beta of 0.68. The company has a quick ratio of 1.19, a current ratio of 1.79 and a debt-to-equity ratio of 1.20.

Baxter International (NYSE:BAX – Get Free Report) last released its quarterly earnings data on Thursday, October 29th. The medical instruments supplier reported $0.58 EPS for the quarter, topping the consensus estimate of $0.52 by $0.06. Baxter International had a positive return on equity of 16.23% and a negative net margin of 6.23%. The firm had revenue of $2.98 billion for the quarter, compared to the consensus estimate of $2.91 billion. During the same quarter in the previous year, the business earned $0.69 earnings per share. The company’s quarterly revenue was up 5.0% on a year-over-year basis. On average, equities analysts forecast that Baxter International Inc. will post 2.10 EPS for the current year.

Baxter International Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Monday, January 4th. Investors of record on Friday, November 27th will be given a dividend of $0.01 per share. This represents a $0.04 annualized dividend and a yield of 0.2%. The ex-dividend date is Friday, November 27th. Baxter International’s dividend payout ratio (DPR) is presently -2.84%.

Wall Street Analyst Weigh In

Several analysts have issued reports on BAX shares. JPMorgan Chase & Co. cut their target price on Baxter International from $26.00 to $25.00 and set a “neutral” rating for the company in a research note on Friday, October 30th. Wall Street Zen upgraded shares of Baxter International from a “hold” rating to a “buy” rating in a research report on Saturday, October 31st. Zacks Research raised shares of Baxter International from a “strong sell” rating to a “hold” rating in a research note on Tuesday, August 11th. Barclays lifted their price target on shares of Baxter International from $20.00 to $23.00 and gave the stock an “underweight” rating in a research note on Monday, November 9th. Finally, Citigroup lowered their price objective on shares of Baxter International from $28.00 to $27.00 and set a “neutral” rating for the company in a report on Monday, October 5th. One investment analyst has rated the stock with a Buy rating, ten have assigned a Hold rating and three have assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Reduce” and an average target price of $23.27.

Read Our Latest Stock Report on Baxter International

About Baxter International

(Free Report)

Baxter International is a global healthcare company that develops and supplies products used in hospitals, clinics and other care settings. Its offerings include intravenous solutions and administration sets, infusion pumps, medication-delivery systems, and products for surgical and hospital care. The company also provides patient-monitoring and connected-care technologies, including products associated with Hillrom, which Baxter acquired in 2021. Its products and services support healthcare professionals and patients in countries around the world.

See Also

Want to see what other hedge funds are holding BAX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Baxter International Inc. (NYSE:BAX – Free Report).

Institutional Ownership by Quarter for Baxter International (NYSE:BAX)

Receive News & Ratings for Baxter International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Baxter International and related companies with MarketBeat.com's FREE daily email newsletter.